Epilepsy phenotypes across the different age-ranges in IQSEC2-related encephalopathy: An Italian multicentre retrospective cohort study.

Children Developmental and epileptic encephalopathies Genetic epilepsies Intellectual disability Neurodevelopmental disorders

Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
04 Jun 2024
Historique:
received: 23 04 2024
revised: 29 05 2024
accepted: 03 06 2024
medline: 9 6 2024
pubmed: 9 6 2024
entrez: 8 6 2024
Statut: aheadofprint

Résumé

Epilepsy is a hallmark of IQSEC2-related encephalopathy within a phenotypic variability ranging between early onset epileptic and developmental encephalopathy and X-linked intellectual disability with epilepsy. Data including demographic aspects, gene variants, seizure semiology and timing, EEG features, neuroimaging and response to therapy were retrospectively collected in patients with IQSEC2-related epilepsy referring to 8 Italian tertiary centres. The reported cohort included 11 patients (8 males and 3 females). Mean age at the onset of epilepsy was 3.90±2.80 years. No cases were reported in the first year of life. No specific epileptic syndromes were recognized. Predominant seizure-types in the age range 12-36 months included focal onset tonic seizures with impaired awareness, myoclonic seizures, and late onset spasms. Generalized motor seizures were predominant in patients between 3 and 6 years and between 12 and 18 years while focal motor seizures with impaired awareness were the most represented types between 6 and 12 years. No patients experienced status epilepticus. EEG patterns included a delayed maturation of EEG organization, irregular focal or diffuse slow activity, multifocal or diffuse epileptiform abnormalities. No structural epileptogenic lesions were detected at MRI. Valproate, lamotrigine, clobazam, topiramate and levetiracetam were the most used antiseizure medication. Complete seizure freedom was achieved only in 2 patients. Onset of epilepsy after the first year of age, predominance of focal seizures with impaired awareness and generalized motor seizures, no pathognomonic underlying epileptic syndrome and infrequent occurrence of status epilepticus emerged as the main features of IQSEC2-related epilepsy phenotype.

Sections du résumé

BACKGROUND BACKGROUND
Epilepsy is a hallmark of IQSEC2-related encephalopathy within a phenotypic variability ranging between early onset epileptic and developmental encephalopathy and X-linked intellectual disability with epilepsy.
PATIENTS AND METHODS METHODS
Data including demographic aspects, gene variants, seizure semiology and timing, EEG features, neuroimaging and response to therapy were retrospectively collected in patients with IQSEC2-related epilepsy referring to 8 Italian tertiary centres.
RESULTS RESULTS
The reported cohort included 11 patients (8 males and 3 females). Mean age at the onset of epilepsy was 3.90±2.80 years. No cases were reported in the first year of life. No specific epileptic syndromes were recognized. Predominant seizure-types in the age range 12-36 months included focal onset tonic seizures with impaired awareness, myoclonic seizures, and late onset spasms. Generalized motor seizures were predominant in patients between 3 and 6 years and between 12 and 18 years while focal motor seizures with impaired awareness were the most represented types between 6 and 12 years. No patients experienced status epilepticus. EEG patterns included a delayed maturation of EEG organization, irregular focal or diffuse slow activity, multifocal or diffuse epileptiform abnormalities. No structural epileptogenic lesions were detected at MRI. Valproate, lamotrigine, clobazam, topiramate and levetiracetam were the most used antiseizure medication. Complete seizure freedom was achieved only in 2 patients.
CONCLUSIONS CONCLUSIONS
Onset of epilepsy after the first year of age, predominance of focal seizures with impaired awareness and generalized motor seizures, no pathognomonic underlying epileptic syndrome and infrequent occurrence of status epilepticus emerged as the main features of IQSEC2-related epilepsy phenotype.

Identifiants

pubmed: 38851096
pii: S1059-1311(24)00160-2
doi: 10.1016/j.seizure.2024.06.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-127

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mario Mastrangelo (M)

Woman/Child Health and Urological Sciences Department, Sapienza University of Rome, Rome, Italy; Unit of Child Neurology and Psychiatry, Department of Neuroscience/Mental Health-Azienda Ospedaliero Universitaria Policlinico Umberto, Rome, Italy. Electronic address: mario.mastrangelo@uniroma1.it.

Carlo Greco (C)

Department of Human Neuroscience-Sapienza, University of Rome, Rome, Italy.

Manuela Tolve (M)

Unit of Clinical Pathology, Azienda Ospedalieo Universitaria Policilinico Umberto I, Rome, Italy.

Emanuele Bartolini (E)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Angelo Russo (A)

Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria dell'età Pediatrica, IRCCS, Bologna, Italy.

Francesco Nicita (F)

Unit of Neuromuscolar and Neurodegenerative Disorders, IRCCS Bambino Gesù Children Hospital, Rome, Italy.

Dario Pruna (D)

Child Neurology and Epilepsy Unit Pediatric Department ARNAS Brotzu Cagliari, Italy.

Jessica Galli (J)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; Unit of Child Neurology and Psychiatry, ASST Spedali Civili of Brescia, Brescia, Italy.

Jacopo Favaro (J)

Pediatric Neurology and Neurophysiology Unit, Department of Women's and Children Health, University of Padua, Padua 35128, Italy.

Gaetano Terrone (G)

Child Neuropsychiatry Unit, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

Claudio De Felice (C)

Pediatrics Unit, University Hospital Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Francesco Pisani (F)

Unit of Child Neurology and Psychiatry, Department of Neuroscience/Mental Health-Azienda Ospedaliero Universitaria Policlinico Umberto, Rome, Italy; Department of Human Neuroscience-Sapienza, University of Rome, Rome, Italy.

Classifications MeSH